Evidence map›Paper›PMID 42861606›Full record

ReviewChemSusChem2026

ZnO Nanowires by Chemical Bath Deposition: A Review on Nucleation, Growth, and Green Chemistry.

Clément Lausecker, Adrien Baillard, Emilien Lefebvre, Estelle Appert, Vincent Consonni

Abstract readReview
In one paragraph

Review in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Clément LauseckerUniversité Grenoble Alpes, CNRS, Grenoble INP, LMGP, Grenoble, France.ORCID https://orcid.org/0000-0001-8139-4029
Adrien BaillardUniversité Grenoble Alpes, CNRS, Grenoble INP, LMGP, Grenoble, France.ORCID https://orcid.org/0000-0001-6675-177X
Emilien LefebvreUniversité Grenoble Alpes, CNRS, Grenoble INP, LMGP, Grenoble, France.ORCID https://orcid.org/0009-0009-9303-7788
Estelle AppertUniversité Grenoble Alpes, CNRS, Grenoble INP, LMGP, Grenoble, France.

Funding

Agence Nationale de la Recherche ANR-10-LABX-55-01Agence Nationale de la Recherche ANR-15-IDEX-02Agence Nationale de la Recherche ANR-17-CE09-0033Agence Nationale de la Recherche ANR-17-CE24-0003Agence Nationale de la Recherche ANR-22-CE09-0032
6 · The paper itself

Abstract

As a sustainable direct wide bandgap semiconductor, ZnO nanowires have received an increasing interest in the past three decades to act as potential building blocks in a large number of functional devices. The chemical bath deposition (CBD) of ZnO nanowires, as a hydrothermal growth operating at low temperature and roughly ambient pressure, can easily be implemented and scaled up for industrial purposes, attracting most of the recent attention in the community. However, despite its relative simplicity, a thorough understanding of the different physicochemical processes at work has emerged as highly critical to ensure ZnO nanowires of high quality. The present review reports a detailed analysis of the most recent and well-established state-of-the-art and scientific challenges of the CBD of ZnO nanowires, including the nucleation and growth processes at work using diverse seed layers, chemicals, and reactors, via the spontaneous and selective area growth approaches. The description of the elongation process of ZnO nanowires through its theoretical modeling is also discussed in detail. Eventually, a special emphasis is placed on the compatibility of the CBD of ZnO nanowires with green chemistry in order to identify its assets and the different opportunities for improvement.

Indexed as

chemical bath depositiongreen chemistrynucleation and growth processZnO nanowire

Identifiers

PMID42861606
PMCPMC13656181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.